Document is current

Any future updates will be listed below

Incidence and outcomes of neuromuscular immune-related adverse events in head and neck cancer patients treated with checkpoint inhibitors

Crossref DOI link: https://doi.org/10.1038/s41598-025-31483-3

Published Online: 2025-12-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark